BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24831943)

  • 1. Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies.
    Teras LR; Rollison DE; Pawlita M; Michel A; Brozy J; de Sanjose S; Blase JL; Gapstur SM
    Int J Cancer; 2015 Jan; 136(1):108-16. PubMed ID: 24831943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma.
    Bertrand KA; Birmann BM; Chang ET; Spiegelman D; Aster JC; Zhang SM; Laden F
    Blood; 2010 Nov; 116(18):3547-53. PubMed ID: 20647565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.
    Kabyemera R; Masalu N; Rambau P; Kamugisha E; Kidenya B; De Rossi A; Petrara MR; Mwizamuholya D
    BMC Pediatr; 2013 Jan; 13():4. PubMed ID: 23294539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus viral load and serology in childhood non-Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: implications for disease risk and characteristics.
    Orem J; Sandin S; Mbidde E; Mangen FW; Middeldorp J; Weiderpass E
    J Med Virol; 2014 Oct; 86(10):1796-803. PubMed ID: 24889739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of epstein-barr virus as a potential cause of B-cell non-Hodgkin lymphoma in a prospective cohort.
    De Roos AJ; Martínez-Maza O; Jerome KR; Mirick DK; Kopecky KJ; Madeleine MM; Magpantay L; Edlefsen KL; Lacroix AZ
    Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1747-55. PubMed ID: 23885038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus infection and risk of lymphoma: immunoblot analysis of antibody responses against EBV-related proteins in a large series of lymphoma subjects and matched controls.
    de Sanjosé S; Bosch R; Schouten T; Verkuijlen S; Nieters A; Foretova L; Maynadié M; Cocco PL; Staines A; Becker N; Brennan P; Benavente Y; Boffetta P; Meijer CJ; Middeldorp JM
    Int J Cancer; 2007 Oct; 121(8):1806-12. PubMed ID: 17557295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas.
    Hamilton-Dutoit SJ; Pallesen G
    Am J Pathol; 1992 Jun; 140(6):1315-25. PubMed ID: 1318639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
    Feng YF; Wu QL; Zong YS
    Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma.
    Coghill AE; Proietti C; Liu Z; Krause L; Bethony J; Prokunina-Olsson L; Obajemu A; Nkrumah F; Biggar RJ; Bhatia K; Hildesheim A; Doolan DL; Mbulaiteye SM
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):57-62. PubMed ID: 31619404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of organohalogen compounds and titres of antibodies to Epstein-Barr virus antigens and the risk for non-Hodgkin lymphoma.
    Hardell K; Carlberg M; Hardell L; Björnfoth H; Ericson Jogsten I; Eriksson M; Van Bavel B; Lindström G
    Oncol Rep; 2009 Jun; 21(6):1567-76. PubMed ID: 19424638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) antibodies in children with non-Hodgkin's lymphomas.
    Roubalová K; Weinreb M; Roubal J; Kodet R; Koutecký J; Vonka V
    Acta Virol; 1988 Jul; 32(4):339-48. PubMed ID: 2903639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated antibody levels to Epstein-Bbarr virus antigens in patients with hairy cell leukemia compared to controls in relation to exposure to pesticides, organic solvents, animals, and exhausts.
    Nordström M; Hardell L; Linde A; Schloss L; Näsman A
    Oncol Res; 1999; 11(11-12):539-44. PubMed ID: 10905566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma.
    Levin LI; Chang ET; Ambinder RF; Lennette ET; Rubertone MV; Mann RB; Borowitz M; Weir EG; Abbondanzo SL; Mueller NE
    Blood; 2012 Nov; 120(18):3750-5. PubMed ID: 22972983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein Barr virus (EBV) carrying cells in blood of Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) patients with high antibody titers against EBV capsid antigens (VCA).
    Lewin N; Aman P; Mellstedt H; Carenfelt C; Klein G; Klein E
    Anticancer Res; 1990; 10(5A):1213-6. PubMed ID: 2173472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer.
    Camargo MC; Kim KM; Matsuo K; Torres J; Liao LM; Morgan D; Michel A; Waterboer T; Song M; Gulley ML; Dominguez RL; Yatabe Y; Kim S; Cortes-Martinez G; Lissowska J; Zabaleta J; Pawlita M; Rabkin CS
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):414-419. PubMed ID: 31719065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
    Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci MG; Ernberg I; Klein G
    Int J Cancer; 1989 Jun; 43(6):1017-21. PubMed ID: 2543639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
    Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
    J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.